{
  "id": 20746520,
  "title": "Antibody-drug conjugate shows promising early results in Phase I trial in sarcoma patients",
  "url": "https://urgent.news/2026/11/19/antibody-drug-conjugate-shows-promising-early-results-in-phase-i",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-19T11:39:42.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-11-antibody-drug-conjugate-early-results.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "An antibody-drug conjugate, a type of drug that targets and enters cancer cells like a Trojan Horse, has shown promising early results across diverse types of soft tissue sarcoma in a Phase I trial. The findings were presented at the 38th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Barcelona, Spain.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}